In this study, eight weekly intramuscular administrations of 50 mg autologous total IgG for seven weeks significantly decreased the clinical severity of AD and increased serum levels of IL-10 and interferon (IFN)-γ at weeks 4, 8, 12, and 16 compared to the baseline without serious adverse events [104]. Here, IL10 is linked to Alzheimer disease.